Home
About
Committee
Activities
Contact
Bioforum

 

.....................................................

מצגת של
ד"ר עפרה אקסלרוד

דרישות רגולטוריות
בנושא איכות בשלבים
הראשונים של פיתוח
תרפיות תאיות מתקדמות

מצגת של
ד"ר סיגלית אריאלי-פורטנוי

ישום GMP בתרפיה
תאית מול יישום GMP
בתרופות כימיות וביולוגיות

.......................................................

Gallery of
Annual Meeting 2013

.......................................................

Gallery of
Training Course -
An Introduction
to Visual
Inspection

.......................................................

Israel-
EU ACAA:
A Milestone
for the Israeli
Pharmaceutical
Community

Presentation of
Dr. Mimi Kaplan

.......................................................

GMP / GXP
Update

Presentation of
Karen S Ginsbury

.......................................................

Greetings and
congratulations to our
friend and colleague
Karen Ginsbury who
won the Gordon
Personeus Award
for her contributions
to PDA!


..........................................................

Welcome to the Israel Chapter   of PDA Website!
The Israel Chapter was founded in 1997 and is made up of the Executive committee, including the president, vice president, treasurer and secretary, the Steering committee and more than 650 individual members. The Chapter promotes professional interaction between its members by bringing together pharmaceutical manufacturers, suppliers, users, academics and regulatory officials to exchange rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production and science in the interest of public health.

PDA MEMBERSHIP APPLICATION


Trend Analysis

Organized by Einat Frydman
Date: 24 July 2014
Location: Kfar Maccabiah, Ramat Gan
Hours: 12:00-16:30
Duration Topic Speaker
12:00 – 12:30 Gathering
12:30 – 13:30 Lunch Break
13:30 – 14:10 Overview of Control Charts: a tool for detecting a trend Raphy Bar
BR Consulting
14:10 – 14:50 Trend analysis as a method for process change investigation – case study Hanna Ben Artzi
BTG
14:50 – 15:00 Coffee Break
15:00 – 15:40 Trends as a part of CPV program – case study Gil Zomber
Teva
15:40 – 16:20 Recovery rates for environmental monitoring USP <1116> Karen Ginsbury
PCI Pharma

For more information please click here

 

 

 


Secretariat


        Home   l   About   l   Committee   l   Activities   l   Contact   l   Bioforum